T. Rowe Price Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-508,872
Closed -$58.7M 2892
2020
Q4
$58.7M Buy
508,872
+33,356
+7% +$3.74M 0.01% 904
2020
Q3
$46.3M Sell
475,516
-105,180
-18% -$12.1M 0.01% 897
2020
Q2
$71.3M Buy
580,696
+86,085
+17% +$9.77M 0.01% 733
2020
Q1
$43.3M Sell
494,611
-225,289
-31% -$23.9M 0.01% 829
2019
Q4
$75.3M Buy
719,900
+290,939
+68% +$32.6M 0.01% 762
2019
Q3
$49.3M Sell
428,961
-16,597
-4% -$2.52M 0.01% 878
2019
Q2
$76.8M Sell
445,558
-27,550
-6% -$4.77M 0.01% 723
2019
Q1
$79.8M Sell
473,108
-28,469
-6% -$4.24M 0.01% 703
2018
Q4
$48.8M Sell
501,577
-249,139
-33% -$32.7M 0.01% 831
2018
Q3
$130M Sell
750,716
-113,133
-13% -$16.3M 0.02% 602
2018
Q2
$121M Buy
863,849
+184,268
+27% +$26.2M 0.02% 610
2018
Q1
$76.6M Sell
679,581
-317,419
-32% -$39.9M 0.01% 716
2017
Q4
$132M Buy
997,000
+36,874
+4% +$4.33M 0.02% 563
2017
Q3
$97.4M Buy
960,126
+146,824
+18% +$15.7M 0.02% 634
2017
Q2
$81.5M Buy
813,302
+79,618
+11% +$8.57M 0.01% 665
2017
Q1
$88.7M Buy
733,684
+266,790
+57% +$32.7M 0.02% 628
2016
Q4
$52.2M Sell
466,894
-74,720
-14% -$8.99M 0.01% 796
2016
Q3
$71.9M Buy
541,614
+379,440
+234% +$36.3M 0.01% 679
2016
Q2
$14.8M Buy
+162,174
New +$13.7M ﹤0.01% 1190
2014
Q3
Sell
-145,724
Closed -$15.6M 2578
2014
Q2
$15.6M Sell
145,724
-153,115
-51% -$10.6M ﹤0.01% 1187
2014
Q1
$17.7M Buy
298,839
+153,709
+106% +$9.14M ﹤0.01% 1147
2013
Q4
$6.03M Hold
145,130
﹤0.01% 1401
2013
Q3
$2.52M Hold
145,130
﹤0.01% 1510
2013
Q2
$1.26M Buy
+145,130
New +$1.28M ﹤0.01% 1604

Other funds holding GWPH